Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury

被引:291
作者
Sawa, T
Yahr, TL
Ohara, M
Kurahashi, K
Gropper, MA
Wiener-Kronish, JP
Frank, DW
机构
[1] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
[2] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA
[6] Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA
关键词
D O I
10.1038/7391
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudomonas aeruginosa is an opportunistic bacterial pathogen that can cause fatal acute lung infections in critically ill individuals. Damage to the lung epithelium is associated with the expression of toxins that are directly injected into eukaryotic cells through a type Ill-mediated secretion and translocation mechanism. Here we show that the P. aeruginosa homolog of the Yersinia V antigen, PcrV, is involved in the translocation of type III toxins. Vaccination against PcrV ensured the survival of challenged mice and decreased lung inflammation and injury. Antibodies to PcrV inhibited the translocation of type III toxins.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 40 条